UBS Group
ROSG

UBS Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

UBS Group’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-58
Closed -$2K – 9825
2014
Q4 		$2K Buy
+58
New +$1.88K ﹤0.01% 9475

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group's ROSG Position: Q2 2018 in Review

UBS Group sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2018, closing a stake of 14,870 shares — an estimated $6K sold.

UBS Group first reported a position in ROSG in Q4 2014 and held it in 12 quarters. The position peaked at $49K in Q2 2016. 2 funds tracked by Wall St. Rank hold ROSG as of Q2 2018.

  • UBS Group reported no remaining Rosetta Genomics Ltd. position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 14,870 Rosetta Genomics Ltd. shares in Q2 2018, an estimated $6K.
  • UBS Group first reported a position in Rosetta Genomics Ltd. in Q4 2014 and held it in 12 quarters.
  • UBS Group's Rosetta Genomics Ltd. position peaked at $49K in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.